Blood-based cancer detection innovation creating infrastructure — breast cancer liquid biopsies detecting circulating tumor DNA enabling early diagnosis without invasive tissue biopsy, establishing blood testing as essential oncology infrastructure, with the Breast Cancer Liquid Biopsy Market experiencing expansion driven by early detection emphasis, non-invasive preference, and...